


Bringing laboratory diagnostics to space
At ADLM 2026, NASA laboratory director Kathleen McMonigal, MD, will discuss how clinical testing and medical monitoring help protect astronauts from the unique health risks of space travel during missions to the International Space Station and beyond. More...30 Jun 2026

Measuring what matters: advancing diversity, equity, and inclusion in lab medicine
An ADLM 2026 session will explore practical, evidence-based strategies for advancing diversity, equity, and inclusion in clinical laboratories to strengthen workforce culture, improve retention, and support more equitable patient care. More...30 Jun 2026

Academy guidance on data analytics: Preparing clinical labs for a data-driven future
A new ADLM guidance document and upcoming 2026 session aim to help clinical laboratories at any stage of digital transformation build effective data analytics programs, emphasizing accessible tools, strong infrastructure, and the critical role of data in advancing AI and patient care. More...30 Jun 2026


In Other News
Emergency Department Opt-Out Testing Program Identifies Undiagnosed HIV
Immune Biomarkers Could Identify Risk of Chronic Critical Illness on ICU Admission
Genomic Assays Predict Anthracycline Benefit in Early-Stage Breast Cancer
Gene Expression Test Refines Melanoma Biopsy Decision-Making
Gene Variants Linked to Pollution-Exacerbated Asthma
Gene Expression Test Refines Melanoma Biopsy Decision-Making
Agilent Strengthens Pathology Capabilities Through Biocare Acquisition
Merck KGaA to Acquire Bio-Techne, Expanding Life Science Portfolio
Gene Variants Linked to Pollution-Exacerbated Asthma
Machine Learning Reveals Consistent Gut Microbiome Patterns in Colorectal Cancer
FDA-Approved Test Identifies Low Risk of Large Esophageal Varices in Cirrhosis
New Cellular Biomarkers Correlate with Disease Severity in Sjögren Disease
Project Aims to Develop First Single-Cell Assay for ADC Therapies
Project Aims to Develop First Single-Cell Assay for ADC Therapies
Airway Immune Signature May Predict Tuberculosis Progression Risk
Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers
Lung Immune Profiling Reveals Distinct Severe Pneumonia Subtypes
Agreement Supports pTau217-Based Alzheimer’s Blood Test Development
Blood Protein Signature Diagnoses Pediatric IBD and Distinguishes Subtypes
Female-Specific RNA Biomarker May Help Explain Sex Differences in Immune Disease
Genetic Marker Supports Anti-TNF Therapy Selection in Crohn’s Disease
Uncertainty-Aware AI Tool Improves Digital Pathology for Cancer Subtyping
Collaboration Aims to Broaden Access to NETosis-Linked Disease Testing








